Corporate Banner
Satellite Banner
Next Gen Sequencing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

OGT Awarded Best Medtech Dealmaker by Oxford Bioscience Network

Published: Wednesday, October 09, 2013
Last Updated: Tuesday, October 08, 2013
Bookmark and Share
Award recognizes OGT’s collaboration with Birmingham and Salisbury NHS Regional Genetics Laboratories.

Oxford Gene Technology (OGT) has won the Best Medtech Dealmaker award at the 2013 Oxford Bioscience Network (OBN) awards held on Wednesday 2 October.

The award recognizes OGT’s collaboration with the Birmingham and Salisbury NHS Regional Genetics Laboratories to develop and launch a 58-gene solid tumour profiling service to advance vital research into personalized cancer care.

The panel, which includes important genes in breast, prostate, ovarian, lung and colorectal cancers, was developed in partnership with research teams at the centres in Birmingham and Salisbury as part of a £1.16 million funding award from the UK Government-backed Technology Strategy Board’s Stratified Medicines programme.

The NHS teams played a key part in the development of the service, validating the tumour profiling assay across different sample types.

Dr Jon Rees, CEO, Oxford Bioscience Network said: “The nature of the collaboration between OGT and Birmingham and Salisbury NHS Regional Genetics Laboratories was of great interest to the OBN Advisory Board, especially as a reflection of the current momentum in healthcare partnerships. The launch of the service in May is testament to how a collaboration of this type can succeed.”

Tim Hall, CFO, who accepted the award for OGT, said, “We value our partnership with the Birmingham and Salisbury NHS Regional Genetics Laboratories very highly. We are pleased that the OBN advisory board recognized the benefits that collaborations between research and industry can bring in the development of ground-breaking medical technologies.”

OGT’s SureSeq™ Solid Tumour Panel Sequencing Service was launched in May 2013, enabling researchers to identify both known and new mutations to develop informed, personalized cancer treatment strategies.

OGT is continuing its work with the research teams in Birmingham and Salisbury to develop the solid tumour profiling assay as a product for launch in early 2014.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

OGT Announces Commercial and Financial Highlights for FY 2015
New products launched across all core brands; Cytocell® FISH, SureSeq™ NGS and CytoSure™ arrays for cancer and rare disease.
Saturday, December 12, 2015
OGT’s Popular ESHG Workshop Free to View Online
Learn about the next generation of microarrays in one of the best attended workshops of the conference.
Friday, July 17, 2015
Oxford Gene Technology Awarded £1.2m Genomics England Contract
Next Generation Sequencing analysis software will support 100,000 Genomes Project by providing intuitive reports for clinical interpretation.
Monday, March 16, 2015
The Role of NGS in Stratified Cancer Medicine
Clinical Scientists reveal the promise and considerations for next generation sequencing in stratified cancer medicine.
Thursday, March 05, 2015
OGT Announces Operational and Financial Highlights for FY 2014
OGT’s molecular genetics business delivers 54% growth in commercial revenues to £11.9m.
Tuesday, December 09, 2014
Pieces of the Puzzle - A Multi-method Approach to Tumour Profiling
OGT workshop provides insight on using complementary genomic technologies.
Friday, November 07, 2014
An Integrated Approach to Clinical Genetics Research
OGT’s new whitepaper explores the next stage of molecular testing.
Wednesday, April 09, 2014
OGT Announces Acquisition of Cytocell Ltd
Company expands leadership in genomic medicine.
Thursday, March 06, 2014
OGT Strengthens Focus on Cancer Biomarkers
Oxford Gene Technology announce the appointment of Dr Bob Holland as Chief Medical Officer.
Monday, October 21, 2013
OGT to Share Strategies for Reliable NGS Panel Assays
Live webinar will focus on enhanced bait design.
Thursday, September 19, 2013
Exploring the Next Generation of Cancer Genomics at BSGM
aCGH to NGS: OGT invites University of Oxford Professor to present latest research.
Thursday, September 12, 2013
A Snapshot of the NGS Market — User Views
Oxford Gene Technology has released the results from a recent survey of researchers using next generation sequencing.
Wednesday, August 21, 2013
New Whitepaper Compares Targeted Resequencing Strategies
OGT provides insight into choice of NGS methods.
Wednesday, July 17, 2013
OGT initiates Strategic Expansion with the Opening of New York Office
Oxford Gene Technology (OGT) announced that it has opened a new office in Tarrytown, New York to support and grow its CytoSure™ cytogenetics arrays and Genefficiency™ next generation sequencing business in the US.
Wednesday, November 21, 2012
OGT Releases New NGS Application Note Focusing on Results, Not Data
Obtaining rapid biological insight from complex NGS datasets.
Monday, August 06, 2012
Scientific News
NASA's DNA Sequencing in Space is a Success
DNA has been sequenced in space for the first time ever for the Biomolecule Sequencer investigation, using the MinION sequencing device.
New Inflammatory Disease Discovered
NIH researchers have discovered a rare and potentially deadly disease - otulipenia - the mostly affects children.
Bringing NGS to the Crime Lab
New technology being validated in BCI lab for use in Ohio missing persons cases.
Expanding Knowledge of Viral Diversity
Environmental datasets help researchers double the number of microbial phyla known to be infected by viruses.
How Cloud Connectivity Can Combat the Reproducibility Crisis
This infographic explains the reproducibility crisis, and how cloud connectivity can help overcome this problem.
The Power of Model Systems
New insights into the influence of host on the gut microbiome are revealed with in situ light sheet fluorescence microscopy and stochastic mathematical modelling.
Mapping Antibody Creation in Humans
Researchers have created the first, detailed map of the body's antibody production, which could suggest new treatment options for immune disorders.
New Way To Measure Important Chemical Modification On RNA
Technology could advance stem cells’ use in regenerative medicine, UCLA researchers say.
Decoding the Genome of the Olive Tree
A team of scientists from three Spanish centers has sequenced, for the first time ever, the complete genome of the olive tree. This work will facilitate genetic improvement for production of olives and olive oil, two key products in the Spanish economy and diet.
Four Newly-Identified Genes Could Improve Rice
A Japanese research team have applied a method used in human genetic analysis to rice and rapidly discovered four new genes that are potentially significant for agriculture. These findings could influence crop breeding and help combat food shortages caused by a growing population.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!